Document:

<PAGE>
                                                                    Exhibit 10.2

                          FIRST AMENDMENT TO SUBLEASE

     This FIRST AMENDMENT TO SUBLEASE (this "Amendment") is made as of March
16, 2004, by and between Antigenics Inc. ("Sublessor"), a Massachusetts
corporation formerly known as Aquila Biopharmaceuticals, Inc. with an address
of 3 Forbes Road, Lexington, Massachusetts 02421 and which is a wholly-owned
subsidiary of Antigenics Inc., a Delaware corporation, and GTC Biotherapeutics,
Inc. ("Sublessee"), a Massachusetts corporation, whose mailing address is 175
Crossing Boulevard, Suite 410, Framingham, Massachusetts 01702.

                              W I T N E S S E T H:

     WHEREAS, Sublessor and Sublessee entered into a Sublease dated July 16,
2002 (the "Sublease");

     WHEREAS, Sublessor and Sublessee desire to amend the Sublease to delete
Sublessee's option to sublease the "Tertiary Space" (as defined in the
Sublease) and otherwise as provided below.

     NOW THEREFORE, for good and valuable consideration, the mutual receipt and
legal sufficiency of which is hereby acknowledged, Sublessor and Sublessee do
hereby agree as follows:

1.   Amendment of Third Whereas Clause. The third Whereas clause of the
Sublease is deleted in its entirety.

2.   Amendment to Section 1(i). The definition of Sublease Termination Date in
Section 1(i) of the Sublease is deleted in its entirety and replaced with the
following: "subject to Section 25 hereof, September 30, 2010."

3.   Amendment of Section 1(j). Section 1(j) of the Sublease is deleted in its
entirety and replaced with the following: "the Subleased Premises consists of
the Primary Space and the Secondary Space as shown on the sketch plan attached
hereto as Exhibit A attached hereto."

4.   Amendment of Sections 1(n) and 1(o). Sections 1(n) and 1(o) of the
Sublease are hereby deleted in their entirety.

5.   Amendment of Section 4(b). Section 4(b) of the Sublease is amended by
adding the words "or Sublessor may" after the second occurrence of the words
"Additional Rent," in the second sentence thereof.

                                      -1-
<PAGE>
6.   Amendment of Section 5(a). Section 5(a) of the Sublease is deleted in its
entirety and replaced with the following: "be in the stated original amount of
not less than Two Hundred Thousand and 00/00 Dollars ($200,000.00);"

7.   Amendment of Section 8. The third sentence of Section 8 is amended by
deleting the phrase ", including the Tertiary Space,".

8.   Amendment of Section 9(a). Section 9(a) of the Sublease is amended by (a)
adding the words "At all times during the term of the Sublease," at the
beginning thereof; (b) adding the phrase "or cause to be provided" after the
word "provide" in the first line thereof and by deleting the phrase "which are
located in the Tertiary Space" and replacing it with the following: "that are
located in the utility equipment area as shown on Exhibit A-1 attached hereto
(the "UTILITY EQUIPMENT AREA") in the second line thereof.

9.   Amendment of Section 9(a)(i). Section 9(a)(i) of the Sublease is amended
by adding the phrase "or cause to be provided" after the word "provide" in the
second line thereof.

10.  Amendment of Section 9(a)(ii). Section 9(a)(ii) of the Sublease is deleted
in its entirety.

11.  Amendment of Section 9(a)(iii). Section 9(a)(iii) of the Sublease is
amended by adding the phrase "or cause to be provided" after the word "provide"
in the first line thereof and by deleting the phrase "utility/maintenance room
located in the Tertiary Space" with the following: "Utility Equipment Area".

12.  Amendment of Section 9(a)(v). The first sentence of Section 9(a)(v) of the
Sublease is amended by deleting the phrase "Utility Services Termination Date"
and replacing it with: "Sublease Termination Date" each time it appears.

13.  Amendment of Section 9(a)(vii). The first sentence of Section 9(a)(vii) of
the Sublease is amended by deleting the phrase "utility/maintenance room in the
Tertiary Space at its sole cost and expense until the Utility Services
Termination Date" and replacing it with the following: "utility/maintenance
room in Utility Equipment Area at its sole cost and expense until the Sublease
Termination Date".

14.  Amendment of Section 9(a)(viii). Section 9(a)(viii) of the Sublease is
amended by deleting the phrase "the earlier of the Sublease Termination Date or
the Sublessee's occupancy of the Tertiary Space" with the following: "the
Sublease Termination Date".

15.  Section 9(b)(iii). Section 9(b)(iii) is deleted in its entirety.

16.  Section 9(b)(iv). The second sentence of Section 9(b)(iv) is deleted in
its entirety.

17.  Heading for Section 11 and Sections 11(a) and 11(b). The heading of
Section 11 is deleted in its entirety and is replaced with the following:
"Right to the Subleased Premises." The first sentence of Section 11 and
Sections 11(a) and 11(b) are deleted in their entirety.

                                      -2-
<PAGE>
18.  Amendment of Section 14(a). Section 14(a) of the Sublease is amended by
deleting the words "Default, as defined in Section 11 of the Prime Lease," and
replacing them with the word "default under the Prime Lease".

19.  Section 17. The second sentence of Section 17 is amended by deleting the
phrase "at 34 Commerce Way, Woburn, Massachusetts 01801, Attention: Mr. Neal
Gordon" and replacing it with the following: "at 3 Forbes Road, Lexington,
Massachusetts 02421, Attention: SVP of Operations".

20.  Section 18. The third sentence of Section 18 is deleted in its entirety.

21.  Section 25. A new Section 25 is added to the Sublease as follows: "EARLY
TERMINATION". Sublessee shall have the right to terminate this Sublease provided
Sublessee shall satisfy the following conditions precedent: (i) there shall be
no default or event of default beyond any applicable grace and/or cure period
pursuant to Section 14 of this Sublease at the time Sublessee exercises its
right to terminate this Sublease or upon the date of termination, (ii) Sublessee
shall give Sublessor with written notice of its election to terminate this
Sublease with such notice being given not later than July 1, 2006 and (iii)
Sublessee has completely vacated the Subleased Premises and fulfilled its
obligations under Section 16 hereof no later than midnight on December 31, 2006.
Should Sublessee comply with the foregoing conditions precedent, the Sublease
Termination Date shall be December 31, 2006, and this Sublease shall terminate
effective at midnight on December 31, 2006. Should Sublessee fail to comply
strictly with any of the foregoing conditions precedent, the rights of Sublessee
under this Section 25 shall be null and void.

22.  Section 26. A new Section 26 is added to the Sublease as follows: "LEASED
PREMISES MONITORING SYSTEM". Sublessor agrees that it shall, at Sublessor's sole
cost and expense, modify the Premises monitoring system for the Leased Premises
in such a manner that Sublessee has an independent system located in the
Subleased Premises to access data collected by the Premises monitoring system
with respect only to the "former animal facility" located in the Subleased
Premises, subject to receipt by Sublessor of the consent of Prime Lessor if such
consent is required. The design of such modifications and the specifications for
any equipment to be purchased and installed by Sublessor in connection with such
modifications shall be subject to Sublessee's prior review and approval, which
approval shall not be unreasonably withheld, conditioned or delayed. Sublessor
shall assign any warranties for the work performed in making such modifications
and for any such equipment to Sublessee.

23.  Amendment of Exhibit A. Exhibit A to the Sublease is deleted in its
entirety and replaced with Exhibit A attached hereto.

24.  Addition of Exhibit A-1. The Sublease is amended by adding Exhibit A-1
attached hereto to the Sublease.

25.  Amendment of Exhibit B. Exhibit B to the Sublease is deleted in its
entirety and replaced with Exhibit B attached hereto.

                                      -3-
<PAGE>
26.  Broker. Sublessor and Sublessee each represent and warrant to the other
than it has not dealt with any broker in connection with this Amendment and
will indemnify and hold harmless the other from and against any loss and
expenses suffered by either of them as a result of such dealings with any
broker.

27.  Prime Lessor's Consent. This Amendment shall be contingent upon the
Sublessor's receipt of the Prime Lessor's written consent to this Amendment.

28.  Confirmation. Except as amended hereby, the Sublease is hereby confirmed
and continues in full force and effect.

29.  Counterparts. This Amendment may be executed in one or more counterparts
which together shall constitute one instrument.

30.  Prior Sublandlord Work. Sublessee hereby acknowledges and confirms to
Sublessor and Prime Lessor that all work and obligations of Sublessor under the
Sublease with respect to the Subleased Premises to be performed on or prior to
the date hereof has been fully performed to the satisfaction of the Sublessee as
of the date hereof, except for the obligations in Paragraph 22 of this
Amendment.

31.  Name of Sublessor. In the Sublease and the Consent to Sublease, a comma
was included in the name of the Sublessor in error. The comma in the name of
the Sublessor under the Sublease and the Consent to Sublease is hereby removed,
and the name Antigenics Inc. without a comma is hereby inserted as the correct
name of the Sublessor in the Sublease and the Consent to Sublease.

32.  Terms; Section References. Terms used herein and not defined herein are
used herein as defined in the Sublease. References herein to Sections of the
Sublease which use "O" to denote clauses refer to applicable sections of the
Sublease even where such parentheses may not be used or "." (or, at various
points, "O" or ".") are used instead in the Sublease.

                                      -4-

<PAGE>
     IN WITNESS WHEREOF, the parties hereto have executed this Amendment, as a
sealed instrument, as of the date first above written.

                                   SUBLESSOR:

                                   Antigenics Inc., a Massachusetts corporation

                                   By:  /s/ Jeff D. Clark
                                      ------------------------------------------
                                      Name: Jeff D. Clark
                                      Title: CFO

                                   SUBLESSEE:

                                   GTC Biotherapeutics, Inc.

                                   By:  /s/ John B. Green
                                      ------------------------------------------
                                      Name: John B. Green
                                      Title: SVP and CFO

                                      -5-
<PAGE>
                                   Exhibit A

                          Primary Space - Third Floor

                                  [FLOORPLAN]

Approximately 11,852 rentable square feet of Subleased Premises

                                                                              22
<PAGE>
                                   Exhibit A

                         Secondary Space - Second Floor

                                  [FLOORPLAN]

Approximately 8,036 rentable square feet of Subleased Premises

Crosshatched Area is Secondary Space

                                                                              21
<PAGE>
                                  EXHIBIT A-1

                                  Sketch Plan

          Utility Equipment Area --                    -- First Floor

                                  [FLOORPLAN]

Approximately 3,449 rentable square feet

                                                                              20
<PAGE>

                                      -8-
<PAGE>
                                   EXHIBIT B

                       FIRST AMENDMENT TO LEASEHOLD LEASE

     This FIRST AMENDMENT TO LEASEHOLD LEASE (this "Amendment") is made as of
March 16, 2004, by and between Antigenics Inc. ("Lessor"), a Massachusetts
Corporation with an address of 3 Forbes Road, Lexington, Massachusetts 02421
and which is a wholly-owned subsidiary of Antigenics Inc., a Delaware
corporation, and GTC Biotherapeutics, Inc. ("Lessee"), a Massachusetts
corporation, whose mailing address is 175 Crossing Boulevard, Suite 410,
Framingham, Massachusetts 01702.

                              W I T N E S S E T H:

     WHEREAS, Lessor and Lessee entered into a Leasehold Lease dated July 19,
2002 (the "Leasehold Lease");

     WHEREAS, Lessor and Lessee desire to amend the Leasehold Lease to delete
Sublessee's rights to lease equipment located in the "Tertiary Space" (as
defined in the Leasehold Lease) and otherwise as provided below.

     NOW THEREFORE, for good and valuable consideration, the mutual receipt and
legal sufficiency of which is hereby acknowledged, Lessor and Lessee do hereby
agree as follows:

1.   Amendment of Second Whereas Clause. The second Whereas clause of the
Leasehold Lease is deleted in its entirety and replaced with the following:
"WHEREAS, Lessor and Lessee entered into a Sublease Agreement dated July 16,
2002, as amended by First Amendment to Sublease dated March 16, 2004 (the
Sublease Agreement, as amended, is referred to as the "Sublease") for a portion
of the Leased Premises (the "Subleased Premised")."

2.   Amendment of the First Paragraph of Section 1. The first paragraph of
Section 1 of the Leasehold Lease (including subparagraphs (a), (b) and (c) is
deleted in its entirety and replaced with the following: "This Leasehold Lease
is for the term beginning on the Sublease Commencement Date and terminating on
the Sublease Termination Date, unless earlier terminated as provided in Section
25 of the Sublease."

3.   Amendment of the Second Paragraph of Section 1. The second paragraph of
Section 1 of the Leasehold Lease is amended by deleting the first sentence in
its entirety and replacing it with the following: "During the term, Lessee
agrees to pay to Lessor the monthly rental amounts set forth as the Leasehold
Improvements Allocation, as adjusted by the Leasehold Improvements Allocation
Reduction (2004 Amendment), in Exhibit B of the Sublease (the "Leasehold Rent")
on or before the first day of each month."

4.   Amendment of Section 2. The first and second sentences of Section 2 of the
Leasehold Lease is amended by deleting the phrase "Primary Space, Secondary
Space and the Tertiary Space" and replacing it with the phrase "Primary Space
and Secondary Space" each time they
<PAGE>
occur. The first sentence of Section 2 is amended by deleting the reference
therein to "Exhibit B" and replacing it with a reference to "Exhibit A"
attached hereto. The third sentence of Section 2 is deleted in its entirety and
replaced with the following: "Lessor shall have no further obligations with
respect to the Equipment after the Sublease Commencement Date."

5.   Amendment of Section 3(a). Section 3(a) is amended by deleting the
reference therein to "Exhibit B" and replacing it with a reference to "Exhibit
A" attached hereto.

6.   Amendment of Section 3(d)(i). The first sentence of Section 3(d)(i) of the
Leasehold Lease is amended by deleting the phrase "for the Primary Space,
Secondary Space and Tertiary Space" and replacing it with the phrase "for the
Primary Space and Secondary Space". The second sentence of Section 3(d)(i) of
the Leasehold Lease is amended by deleting the phrase "and in the event the
Lessee elects to exercise its option to sublease the Tertiary Space, January 1,
2007 with respect to Equipment located in the Tertiary Space".

7.   Amendment of Section 3(d)(iv). The second sentence of Section (d)(i) of
the Leasehold Lease is amended by deleting the phrase "the Primary Space,
Secondary Space and Tertiary Space" and replacing it with the phrase "the
Primary Space and Secondary Space".

8.   Amendment of Section 3(e)(i). Section 3(e)(i) of the Leasehold Lease is
amended by deleting the phrase "the Primary Space, Secondary Space and Tertiary
Space" and replacing it with the phrase "the Primary Space and Secondary
Space". Section 3(i) is further amended by deleting the reference therein to
"Schedule C" and replacing it with a reference to "Exhibit A" attached hereto.

9.   Amendment of Section 3(f)(iii). Section 3(f)(iii) of the Leasehold Lease
is amended by (a) deleting the reference to "Exhibit C" and replacing it with a
reference to "Exhibit B" attached hereto, and (b) deleting the phrase "after
the earlier of the Sublease Termination Date or the Lessee's leasing of the
Tertiary Space" and replacing it with "after the Sublease Termination Date".

10.  Amendment of the Section 10. The second sentence of Section 10 is amended
by deleting the phrase "34 Commerce Way, Woburn, Massachusetts 01801, Attention:
Mr. Neal Gordon" and replacing it with the following: "3 Forbes Road,
Lexington, Massachusetts 02421, Attention: SVP of Operations".

11.  Amendment of Exhibit A. Exhibit A to the Leasehold Lease is deleted in its
entirety and replaced with Exhibit A attached hereto.

12.  Amendment of Exhibit B. Exhibit B to the Leasehold Lease is deleted in its
entirety and replaced with Exhibit B attached hereto.

13.  Amendment of Exhibit C. Exhibit C to the Leasehold Lease is deleted in its
entirety.

14.  Prime Sublessor Consent. This Amendment shall be contingent upon the
Sublessor's receipt of the Prime Sublessor's written consent to this Amendment.

                                      -2-
<PAGE>

15.  Confirmation.  Except as amended hereby, the Leasehold Lease is hereby
confirmed and continues in full force and effect.

16.  Counterparts.  This Amendment may be executed in one or more counterparts
which together shall constitute one instrument.

                                      -3-

<PAGE>
     IN WITNESS WHEREOF, the parties hereto have executed this Amendment, as a
sealed instrument, as of the date first above written.

                                   LESSOR:

                                   Antigenics, Inc., a Massachusetts corporation

                                   By:  /s/ Jeff D. Clark
                                      ------------------------------------------
                                      Name: Jeff D. Clark
                                      Title: CFO

                                   LESSEE:

                                   GTC Biotherapeutics, Inc.

                                   By:  /s/ John B. Green
                                      ------------------------------------------
                                      Name: John B. Green
                                      Title: SVP and CFO
<PAGE>
                                  Exhibit A to
                           Leasehold Lease Agreement
                         Breakdown of Equipment by Room
                           Updated: December 1, 2003

<Table>
<Caption>
          SPACE                         ROOM EQUIPMENT                TAG NUMBER        SERIAL NUMBER       VENDOR
---------------------------------------------------------------------------------------------------------------------
<S>                                  <C>                             <C>                 <C>                <C>
Animal Facility -- Second Floor      246 6' BSC (Ducted)             1226 Cambridge      56-153CIV
                                     246 4' BSC (Ducted)             4223 Aquila                            Nuaire
                                     246 1 Getinge Autoclave         4220 Aquila                            Getinge

Research Labs -- Second Floor        260 Fume Hood                   No Tag                                 Labconco
                                     262 1-4' BSC (Not ducted)       4208 Aquila                            Nuaire
                                     262 1-6' BSC (Not Ducted)       4209 Aquila                            Nuaire
                                     264 Cold Room                                                          Bally
</TABLE>

<PAGE>

<PAGE>
ANTIGENICS, INC.
LEASEHOLD LEASE AGREEMENT - EXHIBIT B TO LEASEHOLD LEASE
ADDITIONAL RENT - LEASEHOLD IMPROVEMENTS
UPDATED: NOVEMBER 14, 2003
PRIMARY SPACE

<Table>
<Caption>
                                                                      PRIMARY SPACE
                                                                      -------------
                                                    Total              Res & Admin
                                                   Spending             3rd Floor
                                                  -----------         -------------
<S>                                               <C>                 <C>
Gross Fixed Assets
 Leasehold Improvements                             5,358,608             1,303,237
                                                  -----------         -------------
 Total Gross Fixed Assets                           5,358,608             1,303,237

Accum. Depr / Amort @ 12/31/01
 Leasehold Improvements                            (1,370,825)             (343,150)
                                                  -----------         -------------
 Total Accum Depr / Amort                          (1,370,825)             (343,150)
                                                  -----------         -------------
Net Gross Fixed Assets                            $ 3,987,783         $     960,087
                                                  ===========         =============
                                                  -----------         -------------
NET EQUIPMENT & LEASEHOLD IMPROVEMENTS            $ 3,987,783         $     960,087
                                                  -----------         -------------
LEASE MONTHS REMAINING @ 12/31/01                                               104

AMORTIZATION OF LHI PER MONTH                                         $    9,231.61
                                                                      =============
</Table>
<PAGE>
ANTIGENICS, INC.
LEASEHOLD LEASE AGREEMENT -- EXHIBIT B (CONTINUED)
ADDITIONAL RENT -- LEASEHOLD IMPROVEMENTS
UPDATED: NOVEMBER 14, 2003
SECONDARY SPACE

<Table>
                                                               SECONDARY SPACE
                                                        --------------------------
                            TOTAL        RES & ADMIN      RESEARCH    E-PRISE SPACE
                          SPENDING        3RD FLOOR      2ND FLOOR      2ND FLOOR
                         ____________   _____________    __________   _____________
<Caption>
<S>                      <C>            <C>               <C>         <C>

Gross Fixed Assets
 Leasehold Improvements    5,358,608       1,303,237        947,178       195,436
                         ____________     ___________     _________      ________

 Total Gross Fixed
  Assets                   5,358,608       1,303,237        947,178       195,436

Accum. Depr/Amort
  @ 12/31/02
  Leasehold
  Improvements            (1,818,334)       (451,063)      (321,405)      (57,481)
                         ___________     ___________      _________      ________
 Total Accum
  Depr/Amort              (1,818,334)       (451,063)      (321,405)      (57,481)
                         ___________     ___________      _________      ________

Net Gross Fixed
 Assets                  $ 3,540,274      $  852,174      $ 625,773      $137,955
                         ===========      ===========     ==========     ========

NET EQUIPMENT &
 LEASEHOLD IMPROVE-      ___________      ___________     __________     ________
  MENTS                  $ 3,540,274      $  852,174      $ 625,773      $137,955
                         ___________      ___________     __________     ________

LEASE MONTHS REMAIN-
 ING @ 12/31/02                                                               92

AMORTIZATION OF LHI
 PER MONTH                                                              $8,301.39
                                                                        =========

</Table><PAGE>

                              EMPLOYMENT AGREEMENT

     THIS AGREEMENT, effective as of March 31, 2004 (the "Effective Date"), is
made by and between Symbol Technologies, Inc., a Delaware corporation (the
"Company") and William R. Nuti (the "Executive").

                                    RECITALS:

     A. It is the desire of the Company to assure itself of the services of the
Executive by continuing the employment of the Executive as its President and
Chief Executive Officer.

     B. The Executive desires to commit himself to serve the Company on the
terms herein provided.

     NOW, THEREFORE, in consideration of the foregoing and of the respective
covenants and agreements set forth below, the parties hereto agree as follows:

     1.   Certain Definitions

          (a) "Affiliate" shall mean with respect to any Person, any other
     Person directly or indirectly, through one or more intermediaries,
     controlling, controlled by, or under common control with, such Person. For
     purposes of this Section 1(a), "control" shall have the meaning given such
     term under Rule 405 of the Securities Act of 1933, as amended.

          (b) "Annual Base Salary" shall have the meaning set forth in Section
     5(a).

          (c) "Board" shall mean the Board of Directors of the Company.

          (d) "Bonus" shall have the meaning set forth in Section 5(b).

          (e) The Company shall have "Cause" to terminate the Executive's
     employment upon (i) the Executive's failure to attempt in good faith to
     substantially perform his duties as President and Chief Executive Officer
     (other than any such failure resulting from the Executive's physical or
     mental incapacity) which is not remedied within 30 days after receipt of
     written notice from the Company specifying such failure; (ii) the
     Executive's failure to attempt in good faith to carry out, or comply with,
     in any material respect any lawful and reasonable written directive of the
     Board or the Executive's willful material violation of the Company's
     Statement of Corporate Policy and Code of Conduct, in either case which is
     not remedied within 30 days after receipt of written notice from the
     Company specifying such failure or violation; (iii) the Executive's
     indictment for, conviction of, or plea of no contest to, or imposition of
     unadjudicated probation for any felony (or any other crime involving fraud,
     embezzlement, misappropriation or moral turpitude having a material adverse
     impact on the Company), other than as a result of vicarious liability or as
     a result of a traffic violation; (iv) the Executive's unlawful use
     (including being under the influence) or

<PAGE>

     possession of illegal drugs on the Company's premises or while performing
     the Executive's duties and responsibilities; or (v) the Executive's
     intentional commission at any time of any act of fraud, embezzlement,
     misappropriation, or breach of fiduciary duty against the Company that has
     a material adverse effect on the Company or that renders the Executive
     unable to perform any of his material duties hereunder.

          (f) "Change in Control" shall occur when:

               (i) A Person (which term, when used in this Section 1(f), shall
          not include the Company, any underwriter temporarily holding
          securities pursuant to an offering of such securities, any trustee or
          other fiduciary holding securities under an employee benefit plan of
          the Company, or any Company owned, directly or indirectly, by the
          stockholders of the Company in substantially the same proportions as
          their ownership of Voting Stock of the Company) is or becomes, without
          the prior consent of a majority of the Continuing Directors, the
          beneficial owner (as defined in Rule 13d-3 promulgated under the
          Securities Exchange Act of 1934, as amended), directly or indirectly,
          of Voting Stock representing, without the prior written consent of a
          majority of the Continuing Directors twenty-five percent (25%) (or,
          even with such prior consent, forty percent (40%)) or more of the
          combined voting power for election of directors of the Company's then
          outstanding securities; or

               (ii) The Company consummates a reorganization, merger or
          consolidation of the Company (which prior to the date of such
          consummation has been approved by the Company's stockholders) or the
          Company sells, or otherwise disposes of, all or substantially all of
          the Company's property and assets (other than a reorganization,
          merger, consolidation or sale which would result in all or
          substantially all of the beneficial owners of the Voting Stock of the
          Company outstanding immediately prior thereto continuing to
          beneficially own, directly or indirectly (either by remaining
          outstanding or by being converted into voting securities of the
          resulting entity), more than fifty percent (50%) of the combined
          voting power of the voting securities of the Company or such entity
          resulting from the transaction (including, without limitation, an
          entity which as a result of such transaction owns the Company or all
          or substantially all of the Company's property or assets, directly or
          indirectly) outstanding immediately after such transaction in
          substantially the same proportions relative to each other as their
          ownership immediately prior to such transaction), or the Company's
          stockholders approve a liquidation or dissolution of the Company; or

               (iii) The individuals who are Continuing Directors of the Company
          (as defined below) cease for any reason to constitute at least a
          majority of the Board.

          (g) "Code" shall mean the Internal Revenue Code of 1986, as amended.

                                       2
<PAGE>

          (h) "Committee" shall mean the Compensation/Stock Option Committee of
     the Board.

          (i) "Common Stock" shall mean the $.01 par value common stock of the
     Company.

          (j) "Company" shall, except as otherwise provided in Section 9, have
     the meaning set forth in the preamble hereto.

          (k) "Competitive Business" shall mean (i) at any time during the Term
     and during the 12-month period immediately following the Date of
     Termination, any entity (which term "entity" shall for purposes of this
     Section 1(k) include any subsidiaries, parent entities or other Affiliates
     thereof) that, as of the Date of Termination, competes with any of the
     businesses of the Company; and (ii) during the period beginning on the
     first anniversary of the Date of Termination and ending on the 18-month
     anniversary of the Date of Termination, those certain entities (which shall
     not number more than 10) designated as "Competitive Businesses" by the
     Committee; provided, however, that, notwithstanding the foregoing, Section
     1(k)(ii) shall not apply in connection with any termination of the
     Executive's employment hereunder due to the Company's non-extension of the
     Term as described in Section 6(a)(vii). In order to effectuate Section
     1(k)(ii), the Committee shall provide the Executive with a written list of
     "Competitive Businesses" on or prior to the 90th day following the Date of
     Termination.

          (l) "Continuing Director" means (i) any member of the Board (other
     than an employee of the Company) immediately following the election of
     directors at the Company's 2004 annual meeting of stockholders or (ii) any
     person who subsequently becomes a member of the Board (other than an
     employee of the Company) whose appointment, election or nomination for
     election to the Board is recommended by a majority of the Continuing
     Directors.

          (m) Date of Termination" shall mean (i) if the Executive's employment
     is terminated by his death, the date of his death; (ii) if the Executive's
     employment is terminated as a result of Disability, the date provided in
     Section 6(a)(ii); and (iii) if the Executive's employment is terminated
     pursuant to Sections 6(a)(iii) - (vi), the date specified in the Notice of
     Termination (or if no such date is specified, the last day of the
     Executive's active employment with the Company), in each case provided in
     accordance with this Agreement.

          (n) "Disability" shall mean any mental or physical illness, condition,
     disability or incapacity which:

               (i) Prevents the Executive from discharging substantially all of
          his essential job responsibilities and employment duties; and

               (ii) Has prevented the Executive from so discharging his duties
          for any 180 days in any 365-day period.

                                       3
<PAGE>

     A Disability shall be deemed to have occurred on the 180th day in any such
     365-day period.

          (o) "Executive" shall have the meaning set forth in the preamble
     hereto.

          (p) "Extension Term" shall have the meaning set forth in Section 2.

          (q) The Executive shall have "Good Reason" to resign his employment
     upon the occurrence of any of the following without the Executive's prior
     written consent: (i) failure of the Company to continue the Executive in
     the position of, and with the title of, President and Chief Executive
     Officer; (ii) a material diminution in the nature or scope of the
     Executive's employment responsibilities, duties or authority or the
     assignment to the Executive of duties or responsibilities that are
     materially and adversely inconsistent with his then position; (iii) failure
     of the Executive to be elected to the Board at any annual meeting of the
     Company's stockholders that occurs during the Term (unless the Executive is
     prohibited from serving as a member of the Board by any applicable law,
     rule or regulation (including without limitation any rule promulgated by
     the New York Stock Exchange)); (iv) relocation of the Company's executive
     offices more than 60 miles east, or 20 miles in any other direction of its
     current location; (v) failure of the Company to timely make any material
     payment or provide any material benefit under this Agreement, or the
     Company's material reduction of any compensation, equity or benefits that
     the Executive is eligible to receive under this Agreement; or (vi) the
     Company's material breach of this Agreement; provided, however, that
     notwithstanding the foregoing the Executive may not resign his employment
     for Good Reason unless: (x) the Executive provides the Company with at
     least 30 days prior written notice of his intent to resign for Good Reason
     (which notice is provided not later than the 90th day following the
     occurrence of the event constituting Good Reason) and (y) the Company does
     not remedy the alleged violation(s) within such 30-day period; and,
     provided, further, that notwithstanding the foregoing if the Executive is
     suspended pursuant to Section 6(a)(iii), such suspension (and any
     corresponding diminution of the Executive's title, duties or compensation,
     or other change to the Executive's employment arrangements described
     hereunder) shall not, in and of itself, give the Executive Good Reason to
     resign his employment.

          (r) "Initial Term" shall have the meaning set forth in Section 2.

          (s) "Intellectual Property" shall have the meaning set forth in
     Section 9(f).

          (t) "Non-Compete Term" shall have the meaning set forth in Section
     9(a).

          (u) "Notice of Termination" shall have the meaning set forth in
     Section 6(b).

          (v) "Option" shall mean an option to purchase Common Stock pursuant to
     the Company's 1997 Employee Stock Option Plan, as amended from time to

                                       4
<PAGE>

     time (or any other equity based compensation plan or agreement that may be
     adopted or entered into by the Company from time to time).

          (w) "Person" shall mean an individual, partnership, corporation,
     business trust, limited liability company, joint stock company, trust,
     unincorporated association, joint venture, governmental authority or other
     entity of whatever nature.

          (x) "Prior Agreement" shall having the meaning set forth in Section
     19.

          (y) "Pro-Rata Bonus" shall have the meaning set forth in Section 7(d).

          (z) "Release" shall have the meaning set forth in Section 7(b).

          (aa) "Retention Program" shall have the meaning set forth in Section
     7(a).

          (bb) "Term" shall have the meaning set forth in Section 2.

          (cc) "Voting Stock" means all capital stock of the Company which by
     its terms may be voted on all matters submitted to stockholders of the
     Company generally.

     2. Employment. Subject to Section 6, the Company shall employ the Executive
and the Executive shall continue in the employ of the Company, for the period
set forth in this Section 2, in the positions set forth in the first sentence of
Section 3 and upon the other terms and conditions herein provided. The initial
term of employment under this Agreement (the "Initial Term") shall be for the
period beginning on the Effective Date and ending on July 31, 2009, unless
earlier terminated as provided in Section 6. The Initial Term shall
automatically be extended for successive one-year periods (each, an "Extension
Term") unless either party hereto gives written notice of non-extension to the
other party no later than 60 days prior to the scheduled expiration of the
Initial Term or the then applicable Extension Term (the Initial Term and any
Extension Term shall be collectively referred to hereunder as the "Term").

     3. Position and Duties. The Executive shall serve as President and Chief
Executive Officer of the Company, reporting directly to the Board, with such
responsibilities, duties and authority as are customary for such role. During
the Term, the Company shall nominate the Executive for a seat on the Board upon
the expiration of Executive's current term as a director, and upon the
expiration of each subsequent term thereafter (or, in the event that the
Executive is not elected to the Board at any annual meeting of the Company's
stockholders, at not less than one annual meeting following the first annual
meeting at which he in not elected). The Executive also agrees to serve, without
additional compensation, as the chief executive officer or director of any
subsidiary, division or Affiliate of the Company if so requested by the Board.
The Executive shall devote substantially all of his business time, attention and
efforts, toward the performance of his duties under this Agreement.
Notwithstanding the foregoing, the Executive may manage his personal
investments, be involved in charitable and professional activities (including
serving on charitable and professional boards), and, with the consent of the

                                       5
<PAGE>

Board, serve on for-profit boards of directors and advisory committees so long
as such service does not materially interfere with the performance of the
Executive's duties hereunder or violate Section 9 hereof, provided that any
boards that the Executive serves on as of the Effective Date and which have been
previously approved shall be deemed to be continued as approved.

     4. Place of Performance. In connection with his employment during the Term,
the Executive shall be based at the Company's offices in Holtsville, New York,
except for necessary travel on the Company's business.

     5. Compensation and Related Matters

          (a) Annual Base Salary. At the commencement of the Term, the Executive
     shall receive a base salary at a rate of $1,000,000 per annum (the "Annual
     Base Salary"), paid in accordance with the Company's general payroll
     practices for executives, but no less frequently than monthly. No less
     frequently than annually during the Term, the Board and the Committee shall
     review the rate of Annual Base Salary payable to the Executive, and may, in
     their discretion, increase (but not decrease) the rate of Annual Base
     Salary payable hereunder; provided, however, that any increased rate shall
     thereafter be the rate of "Annual Base Salary" hereunder.

          (b) Bonus. Except as otherwise provided for herein, with respect to
     (i) 2004 and (ii) each subsequent fiscal year on which the Executive is
     employed hereunder on the last day of the applicable year, the Executive
     shall be eligible to receive a bonus (the "Bonus"), as determined pursuant
     to the Company's Executive Bonus Plan or another "qualified
     performance-based compensation" bonus plan that has been approved by the
     stockholders of the Company in accordance with the provisions for such
     approval under Code Section 162(m) and the regulations promulgated
     thereunder (collectively, the "Bonus Plan"), and on the basis of the
     Executive's or the Company's attainment of objective financial or other
     operating criteria established by the Committee in its sole good faith
     discretion and in accordance with Code Section 162(m) and the regulations
     promulgated thereunder. With respect to each fiscal year during the Term
     (i) the Executive shall be eligible to receive a maximum Bonus in an amount
     equal to 200% of his Annual Base Salary and (ii) the Executive's
     target-level Bonus shall be equal to 100% of the amount of his Annual Base
     Salary. The Bonus for each fiscal year shall be paid to the Executive no
     later than 90 days following the completion of such fiscal year. In
     addition, the Executive shall be eligible to participate in any other bonus
     plan or program that may be established by the Committee and that covers
     the Executive (even if such plan or program does not provide for qualified
     performance-based bonuses within the meaning of Code Section 162(m)), at a
     level commensurate with the Executive's position.

          (c) Equity Awards

               (i) During the Term, the Executive shall be eligible to be
          granted Options and other equity compensation awards at such time(s)
          and in such amount(s) as may be determined by the Committee in its
          sole discretion, at a level commensurate with the Executive's
          position.

                                       6
<PAGE>

               (ii) In addition to any Options or other equity compensation
          awards granted in accordance with subsection (i), in recognition of
          his promotion to the position of Chief Executive Officer of the
          Company effective as of December 30, 2003, as soon as reasonably
          practicable following the Effective Date the Executive shall be
          granted an Option or other equity compensation award at a level
          commensurate with the Executive's position and upon such terms and
          conditions as shall be determined by the Committee and set forth in a
          written award agreement between the Executive and the Company.

               (iii) Notwithstanding any provision to the contrary in any Option
          agreement, effective immediately upon the occurrence of a Change in
          Control, all Options and other equity compensation awards then held by
          the Executive shall become fully vested and exercisable with respect
          to all shares subject thereto.

               (iv) Upon a termination of the Executive's employment for any
          reason, other than for Cause, any Option that is granted on or
          following the Effective Date and that is exercisable as of the date of
          such termination of employment shall remain exercisable for at least
          180 days following the date of termination of employment, but not
          beyond the original term of such Option.

          (d) Benefits. The Executive shall be entitled to receive such benefits
     (including, without limitation, fringe benefits and perquisites) and to
     participate in such employee group benefit plans, including life, health
     and disability insurance policies and the Company's Code Section 401(k)
     pension plan, as are generally provided by the Company to its senior
     executives in accordance with the plans, practices and programs of the
     Company, at a level commensurate with the Executive's position. In
     addition, the Executive shall continue to participate in the Company's
     Executive Retirement Plan, as amended from time to time.

          (e) Expenses. The Company shall reimburse the Executive for all
     reasonable and necessary expenses incurred by the Executive in connection
     with the performance of the Executive's duties as an employee of the
     Company. Such reimbursement is subject to the submission to the Company by
     the Executive of appropriate documentation and/or vouchers in accordance
     with the customary procedures of the Company for expense reimbursement, as
     such procedures may be revised by the Company from time to time and to such
     caps on reimbursement as the Company may from time to time impose.

          (f) Vacations. The Executive shall be entitled to paid vacation in
     accordance with the Company's vacation policy as in effect from time to
     time. However, in no event shall the Executive be entitled to less than
     four weeks vacation per annum. The Executive shall also be entitled to paid
     holidays and personal days in accordance with the Company's practice with
     respect to same as in effect from time to time.

          (g) Automobile. During the Term, the Company shall provide the
     Executive with use of a Company-leased automobile, based on an allowance or
     lease

                                       7
<PAGE>

     allotment of up to $1,000 per month, and shall pay gasoline, maintenance
     and insurance expenses for such automobile.

     6. Termination. The Executive's employment hereunder may be terminated by
the Company, on the one hand, or the Executive, on the other hand, as
applicable, without any breach of this Agreement only under the following
circumstances:

          (a) Terminations

               (i) Death. The Executive's employment hereunder shall terminate
          upon his death.

               (ii) Disability. In the event of the Executive's Disability, the
          Company may give the Executive written notice of its intention to
          terminate the Executive's employment while he remains so disabled. In
          such event, the Executive's employment with the Company shall
          terminate effective on the 14th day after delivery of such notice,
          provided that within the 14 days after such delivery, the Executive
          shall not have returned to full-time performance of his duties.

               (iii) Cause. The Board may, with the approval of a majority of
          the Continuing Directors after a meeting (of which the Executive is
          provided with at least 10 days prior written notice of the intent of
          the meeting and the specifics of the grounds for Cause termination
          being alleged) at which the Executive has been given an opportunity to
          appear with counsel, terminate the Executive's employment hereunder
          for Cause. If the Board has reasonable belief that the Executive has
          committed any act or omission that has resulted in or that may
          reasonably be expected to result in the occurrence any of the events
          described in Section 1(e)(iii), the Board may suspend the Executive
          while it investigates whether to terminate the Executive's employment
          for Cause. During any such suspension period (which may not be longer
          in the aggregate than 12 consecutive months (including any renewals))
          (the "Suspension Period") the Executive shall continue to
          ----------------- receive his Annual Base Salary and the benefits
          described in Section 5(d); provided, that if the Executive ultimately
          is convicted of, pleads no contest to, or receives unadjudicated
          probation for, any felony (or any other crime involving fraud,
          embezzlement, misappropriation or moral turpitude having a material
          adverse impact on the Company), other than as a result of vicarious
          liability or as a result of a traffic violation, then the Executive
          shall repay to the Company all amounts of Annual Base Salary paid to
          him by the Company with respect to the Suspension Period.
          Notwithstanding any other provision of this Agreement (or any Option
          or other equity compensation award agreement) to the contrary, no
          Option or other equity compensation award held by the Executive shall
          become vested or exercisable during the Suspension Period; provided,
          that if the Executive's employment is not ultimately terminated for
          Cause any Option or other equity compensation award (or portion
          thereof) that would have otherwise become vested or exercisable during
          the Suspension Period shall become vested or exercisable following the
          expiration of the Suspension Period (and not less than

                                       8
<PAGE>

          10 business days prior to the Date of Termination). No Bonus shall be
          payable to the Executive with respect to the Suspension Period (but
          the Executive shall remain eligible to receive a pro-rata Bonus with
          respect to any portion of the fiscal year in which the Suspension
          Period commences that has elapsed prior to the commencement of the
          Suspension Period, to the extent such Bonus would otherwise have been
          payable to the Executive with respect to such fiscal year pursuant to
          the terms of the Bonus Plan). The Company may terminate the
          Executive's employment at any time following the commencement of the
          Suspension Period upon 10 days written notice to the Executive.

               (iv) Good Reason. The Executive may terminate his employment for
          Good Reason; provided that if such termination is due to the
          Executive's failure to be elected to the Board as described in Section
          1(q)(iii), then the Executive shall provide the Company with not less
          than 60 days advanced written notice of such termination.

               (v) Without Cause. The Company may terminate the Executive's
          employment without Cause upon 30 days written notice to the Executive.

               (vi) Resignation without Good Reason. The Executive may resign
          his employment without Good Reason upon 60 days written notice to the
          Company.

               (vii) Non-Extension of Term. The Executive's employment shall
          terminate as of the last day of the Term if either party provides
          notice of non-extension of the Term to the other pursuant to Section
          2.

          (b) Notice of Termination. Any termination of the Executive's
     employment by the Company or by the Executive under this Section 6 (other
     than termination pursuant to paragraph (a)(i) or (a)(vii)) shall be
     communicated by a written notice to the other party hereto indicating the
     specific termination provision in this Agreement relied upon, setting forth
     in reasonable detail any facts and circumstances claimed to provide a basis
     for termination of the Executive's employment under the provision so
     indicated, and specifying a Date of Termination in accordance with this
     Agreement (a "Notice of Termination"); provided, the Company may suspend
     the Executive from his positions with pay during any notice period so long
     as he is retained as an employee of the Company during such notice period.

     7. Severance Payments and Benefits

          (a) Termination for any Reason. In the event the Executive's
     employment with the Company is terminated for any reason, as soon as
     reasonably practicable after such termination the Company shall pay the
     Executive (or his beneficiary in the event of his death) a lump sum equal
     to any unpaid Annual Base Salary that has accrued as of the Date of
     Termination, any unreimbursed expenses due to the Executive and an amount
     for any accrued but unused vacation days and any earned but

                                       9
<PAGE>

     unpaid Bonus for any fiscal year of the Company completed prior to the date
     of such termination. The Executive shall also be entitled to accrued,
     vested benefits under the Company's benefit plans and programs as provided
     therein. In addition, any shares of Common Stock held by the Executive
     shall cease to be subject to the Company's 2002 Stock Ownership and Option
     Retention Program (or any successor thereto) (the "Retention Program") and
     any shares held in escrow under Section 5 of the Retention Program shall
     immediately be released to the Executive (with any restrictive legends
     imposed because of the Retention Program having been removed) and any
     forfeiture provisions applicable under the Retention Program shall cease to
     apply. The Executive shall be entitled to the cash severance payments
     described below only as set forth herein and the provisions of this Section
     7 shall supersede in their entirety any severance payment provisions in any
     severance plan, policy, program or arrangement maintained by the Company.

          (b) Terminations without Cause or for Good Reason. Except as otherwise
     provided by Section 7(c) with respect to certain terminations of employment
     in connection with a Change in Control, if the Executive's employment shall
     terminate without Cause (pursuant to Section 6(a)(v)), or for Good Reason
     (pursuant to Section 6(a)(iv)), the Company shall (subject to the
     Executive's entering into a Separation and Release Agreement with the
     Company in substantially the form attached hereto as Exhibit A (the
     "Release")):

               (i) Pay to the Executive an amount equal to the product of (A)
          the sum of his then current (i) Annual Base Salary and (ii) the
          greater of (1) the Bonus paid or payable to Executive with respect to
          the fiscal year ending immediately prior to the Date of Termination or
          (2) 50% of the target Bonus for such year, and (B) 1.5; payable in
          equal monthly installments during the period beginning on the Date of
          Termination and ending on the 18 month anniversary thereof; provided,
          however, that no amount shall be payable pursuant to this Section
          7(b)(i) on or following the date the Executive first (i) breaches any
          of the covenants set forth in Sections 9(a) or 9(b), or (ii)
          materially breaches any of the covenants set forth in Section 9(c) or
          9(e), which is not remedied (if remediable) within 30 days after
          receipt of written notice from the Company specifying such breach;

               (ii) Continue to provide the Executive (and his dependents) with
          all health and welfare benefits and perquisites which he (or his
          dependents) was participating in or receiving as of the Date of
          Termination (at a level then in effect with respect to coverage and
          employee premiums) until the earlier of (A) the 18 month anniversary
          of the Date of Termination or (B) the date the Executive first (i)
          breaches any of the covenants set forth in Sections 9(a) or 9(b), or
          (ii) materially breaches any of the covenants set forth in Section
          9(c) or 9(e), which is not remedied (if remediable) within 30 days
          after receipt of written notice from the Company specifying such
          breach. If such benefits cannot be provided under the Company's
          programs, such benefits and perquisites will be provided on an
          individual basis to the Executive such that his after-tax costs will
          be no greater than the costs for such benefits and perquisites under
          the Company's programs;

                                       10
<PAGE>

               (iii) Pay to the Executive a Pro-Rata Bonus, as defined in
          Section 7(d), when bonuses are paid for the year of termination.

          (c) Certain Terminations in connection with a Change in Control. If
     the Executive's employment shall terminate without Cause (pursuant to
     Section 6(a)(v)) or for Good Reason (pursuant to Section 6(a)(iv)) during
     the period commencing six months prior to, and ending 18-months after, a
     Change in Control, in any such case, the Company shall (subject to the
     receipt of the Release):

               (i) Pay to the Executive an amount equal to the product of (A)
          the sum of his then current (i) Annual Base Salary and (ii) the target
          Bonus payable to Executive with respect to the fiscal year ending
          immediately prior to the Date of Termination, and (B) three; payable
          in a lump sum as soon as reasonably practicable after such termination
          of employment (or, if such termination occurs prior to the
          consummation of the Change in Control, as soon as reasonably
          practicable after the effective date of such Change in Control);

               (ii) Continue to provide the Executive (and his dependents) with
          all health and welfare benefits and perquisites which he (or his
          dependents) was participating in or receiving as of the Date of
          Termination (at a level then in effect with respect to coverage and
          employee premiums) until the earlier of (A) third anniversary of the
          Date of Termination or (B) the date the Executive first (i) breaches
          any of the covenants set forth in Sections 9(a) or 9(b), or (ii)
          materially breaches any of the covenants set forth in Section 9(c) or
          9(e) which is not remedied (if remediable) within 30 days after
          receipt of written notice from the Company specifying such breach. If
          such benefits cannot be provided under the Company's programs, such
          benefits and perquisites will be provided on an individual basis to
          the Executive such that his after-tax costs will be no greater than
          the costs for such benefits and perquisites under the Company's
          programs;

               (iii) Pay Executive a Pro-Rata Bonus, as defined in Section 7(d),
          when bonuses are paid for the year of termination;

               (iv) Notwithstanding any other provision of this Agreement, the
          parties acknowledge and agree that Sections 7(b) and 7(c) shall
          operate in the alternative and that any payments and benefits that the
          Executive shall be entitled to receive pursuant to this Section 7(c)
          in connection with a termination of his employment and the subsequent
          occurrence of a Change in Control shall be offset by payments and
          benefits received by the Executive pursuant to Section 7(b) on or
          prior to the effective date of such Change in Control.

          (d) Termination by Reason of Disability or Death. If the Executive's
     employment shall terminate by reason of his Disability (pursuant to Section
     6(a)(ii)) or death (pursuant to Section 6(a)(i)), then the Company shall
     pay to the Executive (or Executive's estate) when bonuses are paid for the
     year of termination a pro-rated amount of the Executive's Bonus for the
     fiscal year in which the Date of Termination occurs equal to the product of
     (i) the amount of the Bonus the Executive would have otherwise

                                       11
<PAGE>

     earned had he been employed by the Company on the last day of the fiscal
     year in which the Date of Termination occurs and (ii) the ratio of (A) the
     number of days elapsed during such fiscal year prior to the Date of
     Termination to (B) 365 (the "Pro-Rata Bonus"), and provide the Executive
     (and his dependents), as applicable, with the continued health coverage
     described in Section 7(b)(ii).

          (e) Non-Extension of Term by the Company. If the Company notifies the
     Executive that it will not extend the Term as provided by Section 2, then
     in connection the Executive's termination of employment as of the last day
     of the Term the Company shall (subject to the Executive's entering into a
     Separation and Release Agreement with the Company in substantially the form
     attached hereto as Exhibit A (the "Release")):

               (i) Pay to the Executive an amount equal to the product of (A)
          the sum of his then current (i) Annual Base Salary and (ii) the
          greater of (1) the Bonus paid or payable to Executive with respect to
          the fiscal year ending immediately prior to the Date of Termination or
          (2) 50% of the target Bonus for such year, and (B) one; payable in
          equal monthly installments during the period beginning on the Date of
          Termination and ending on the first anniversary thereof; provided,
          however, that no amount shall be payable pursuant to this Section
          7(e)(i) on or following the date the Executive first (i) breaches any
          of the covenants set forth in Sections 9(a) or 9(b), or (ii)
          materially breaches any of the covenants set forth in Section 9(c) or
          9(e), which is not remedied (if remediable) within 30 days after
          receipt of written notice from the Company specifying such breach;

               (ii) Continue to provide the Executive (and his dependents) with
          all health and welfare benefits and perquisites which he (or his
          dependents) was participating in or receiving as of the Date of
          Termination (at a level then in effect with respect to coverage and
          employee premiums) until the earlier of (A) the first anniversary of
          the Date of Termination or (B) the date the Executive first (i)
          breaches any of the covenants set forth in Sections 9(a) or 9(b), or
          (ii) materially breaches any of the covenants set forth in Section
          9(c) or 9(e), which is not remedied (if remediable) within 30 days
          after receipt of written notice from the Company specifying such
          breach. If such benefits cannot be provided under the Company's
          programs, such benefits and perquisites will be provided on an
          individual basis to the Executive such that his after-tax costs will
          be no greater than the costs for such benefits and perquisites under
          the Company's programs;

               (iii) Pay to the Executive a Pro-Rata Bonus, as defined in
          Section 7(d), when bonuses are paid for the year of termination.

     For the avoidance of doubt, no amount shall be payable to the Executive
     pursuant to this Section 7(e) if the Executive's employment is terminated
     due to the Executive's (rather than the Company's) notification of
     non-extension of the Term pursuant to Section 2.

                                       12
<PAGE>

          (f) Survival. The expiration or termination of the Term shall not
     impair the rights or obligations of any party hereto which shall have
     accrued hereunder prior to such expiration.

          (g) No Mitigation/Set-Off. The Executive shall have no obligation to
     mitigate any payments due hereunder. Any amounts earned by the Executive
     from other employment shall not offset amounts due hereunder, except as
     provided in this Section 7. The Company's obligation to pay the Executive
     the amounts provided hereunder shall not be subject to set-off,
     counterclaim or recoupment of amounts owed by the Executive to the Company
     or its affiliates, except (i) as provided by Section 7(c)(iv) and (ii) for
     any specific, stated amounts owed by the Executive to the Company as
     evidenced by a writing signed by the Executive.

     8. Parachute Payments.

          (a) If it is determined by a nationally recognized United States
     public accounting firm selected by the Company and approved in writing by
     the Executive (which approval shall not be unreasonably withheld) (the
     "Auditors") that any payment or benefit made or provided to the Executive
     in connection with this Agreement or otherwise (including without
     limitation any Option or other equity compensation award vesting)
     (collectively, a "Payment"), would be subject to the excise tax imposed by
     Section 4999 of the Code (the "Parachute Tax"), then the Company shall pay
     to the Executive, prior to the time the Parachute Tax is payable with
     respect to such Payment, an additional payment (a "Gross-Up Payment") in an
     amount such that, after payment by the Executive of all taxes (including
     any Parachute Tax) imposed upon the Gross-Up Payment, the Executive retains
     an amount of the Gross-Up Payment equal to the Parachute Tax imposed upon
     the Payment. The amount of any Gross-Up Payment shall be determined by the
     Auditors, subject to adjustment, as necessary, as a result of any Internal
     Revenue Service position. For purposes of making the calculations required
     by this Agreement, the Auditors may make reasonable assumptions and
     approximations concerning applicable taxes and may rely on reasonable, good
     faith interpretations concerning the application of Sections 280G and 4999
     of the Code, provided that the Auditors' determinations must be made with
     substantial authority (within the meaning of Section 6662 of the Code). To
     the extent that the Company obtains a written opinion from the Auditors
     with respect to Parachute Tax issues, the Company shall direct the Auditors
     to extend such opinion to the Executive (to the extent that such extension
     is permitted by the Auditors); provided, that in no event shall the Company
     be required to obtain such an opinion.

          (b) The federal tax returns filed by the Executive (and any filing
     made by a consolidated tax group which includes the Company) shall be
     prepared and filed on a basis consistent with the determination of the
     Auditors with respect to the Parachute Tax payable by the Executive. The
     Executive shall make proper payment of the amount of any Parachute Tax
     based on such determination, and at the request of the Company, provide to
     the Company true and correct copies (with any amendments) of his federal
     income tax return as filed with the Internal Revenue Service, and such
     other documents reasonably requested by the Company, evidencing such
     payment, provided that any

                                       13
<PAGE>

     information unrelated to the Parachute Tax may be deleted from the copies
     of the returns and documents delivered to the Company. If, after the
     Company's payment to the Executive of the Gross-Up Payment, the Auditors
     determine in good faith that the amount of the Gross-Up Payment should be
     reduced or increased, or a determination is made by the Internal Revenue
     Service that would make the prior Gross-Up Payment amount not accurate,
     then within ten business days of such determination, the Executive shall
     pay to the Company the amount of any such reduction, or the Company shall
     pay to the Executive the amount of any such increase; provided, however,
     that in no event shall the Executive have any such refund obligation if it
     is determined by the Company that to do so would be a violation of the
     Sarbanes-Oxley Act of 2002, as it may be amended from time to time; and
     provided, further, that if the Executive has prior thereto paid such
     amounts to the Internal Revenue Service, such refund shall be due only to
     the extent that a refund of such amount is received by the Executive; and
     provided, further, that (i) the fees and expenses of the Auditors (and any
     other legal and accounting fees) incurred for services rendered in
     connection with the Auditor's determination of the Parachute Tax or any
     challenge by the Internal Revenue Service or other taxing authority
     relating to such determination shall be paid by the Company and (ii) the
     Company shall indemnify and hold the Executive harmless on an after-tax
     basis for any interest and penalties imposed upon the Executive to the
     extent that such interest and penalties are related to the Auditors'
     determination of the Parachute Tax or the Gross-Up Payment. Notwithstanding
     anything to the contrary herein, the Executive's rights under this Section
     8 shall survive the termination of his employment for any reason and the
     termination or expiration of this Agreement for any reason.

     9. Certain Restrictive Covenants

          (a) The Executive shall not, at any time during the Term or during the
     18-month period following the Date of Termination (or, in the event of any
     termination of the Executive's employment pursuant to Section 6(a)(vii) due
     to the Company's non-extension of the Term, the 12-month period following
     the Date of Termination) (either such period, the "Non-Compete Term")
     without the Board's prior written consent directly or indirectly engage in,
     have any equity interest in, or manage or operate (whether as a director,
     officer, employee, agent, representative, security holder, consultant or
     otherwise) any Competitive Business; provided, however, that: (x) the
     Executive shall be permitted to acquire a passive stock or equity interest
     in such a Competitive Business provided the stock or other equity interest
     acquired is not more than five percent (5%) of the outstanding interest in
     such a Competitive Business; or (y) the Executive shall be permitted to
     acquire any investment through a mutual fund, private equity fund or other
     pooled account that is not controlled by the Executive and which he has
     less than a five percent (5%) interest. At any time during the Non-Compete
     Term following the Date of Termination, the Executive may request in
     writing to the Board that the Board consent to the Executive's direct or
     indirect engagement in, ownership of equity interest in, or management or
     operation of (whether as a director, officer, employee, agent,
     representative, security holder, consultant or otherwise) any Competitive
     Business, which request the Board shall consider in good faith based upon
     the Board's reasonable determination of the potential impact of the
     Executive's involvement in such Competitive Business on the Company and its
     stockholders. If the Executive believes that the Board

                                       14
<PAGE>

     would benefit from any additional information or if the Executive has any
     issues or questions regarding any action taken or to be taken by the Board
     in connection with this Section 9(a), then the Board and the Executive
     (along with their respective representatives) shall meet and discuss any
     such issues or questions and the Executive shall be permitted to present
     the Board with any relevant information that he deems appropriate and the
     Board and the Executive shall act in good faith to address all outstanding
     issues and questions while protecting the interests of the Company and its
     stockholders.

          (b) During the 24 month period following the Date of Termination, the
     Executive will not, directly or indirectly recruit or otherwise solicit or
     induce any non-clerical employee, director, consultant, wholesale customer,
     vendor, supplier, lessor or lessee of the Company to terminate his or its
     employment or arrangement with the Company or otherwise change its
     relationship with the Company.

          (c) Except as the Executive deems necessary (or, in good faith,
     desirable) to be disclosed in connection with the performance of the
     Executive's duties hereunder or as specifically set forth in this Section
     9, the Executive shall, in perpetuity, maintain in confidence and shall not
     directly, indirectly or otherwise, use, disseminate, disclose or publish,
     or use for his benefit or the benefit of any person, firm, corporation or
     other entity any confidential or proprietary information or trade secrets
     of or relating to the Company, including, without limitation, information
     with respect to the Company's operations, processes, products, inventions,
     business practices, finances, principals, vendors, suppliers, customers,
     potential customers, marketing methods, costs, prices, contractual
     relationships, regulatory status, business plans, designs, marketing or
     other business strategies, compensation paid to employees or other terms of
     employment, or deliver to any person, firm, corporation or other entity any
     document, record, notebook, computer program or similar repository of or
     containing any such confidential or proprietary information or trade
     secrets. Notwithstanding anything herein to the contrary, nothing shall
     prohibit the Executive from disclosing any information that is generally
     known by the public. The parties hereby stipulate and agree that as between
     them the foregoing matters are important, material and confidential
     proprietary information and trade secrets and affect the successful conduct
     of the businesses of the Company (and any successor or assignee of the
     Company). Upon termination of the Executive's employment with the Company
     for any reason, the Executive will promptly deliver to the Company all
     correspondence, drawings, manuals, letters, notes, notebooks, reports,
     programs, plans, proposals, financial documents, or any other documents
     concerning the Company's customers, business plans, designs, marketing or
     other business strategies, products or processes, provided that the
     Executive may retain his rolodex, address book and similar information and
     any non-proprietary documents he received as a director.

          (d) Notwithstanding Section 9(c), the Executive may respond to a
     lawful and valid subpoena or other legal process or other government or
     regulatory inquiry but shall give the Company prompt notice thereof (except
     to the extent legally prohibited), and shall, as much in advance of the
     return date as is reasonably practicable, make available to the Company and
     its counsel copies of any documents sought which are in the Executive's
     possession or to which the Executive otherwise has reasonable

                                       15
<PAGE>

     access. In addition, the Executive shall reasonably cooperate with and
     assist the Company and its counsel at any time and in any manner reasonably
     required by the Company or its counsel (with due regard for the Executive's
     other commitments if he is not employed by the Company) in connection with
     any litigation or other legal process affecting the Company of which the
     Executive has knowledge as a result of his employment with the Company
     (other than any litigation with respect to this Agreement). In the event of
     such requested cooperation, the Company shall reimburse the Executive's
     reasonable out of pocket expenses.

          (e) The Executive shall not intentionally disparage the Company, any
     of its products or practices, or any of its directors, officers, or
     employees, whether orally, in writing or otherwise, at any time. The
     Company (including without limitation its directors) shall not
     intentionally disparage the Executive, whether orally, in writing or
     otherwise, at any time. Notwithstanding the foregoing: (i) nothing in this
     Section 9(e) shall limit the ability of the Company or the Executive, as
     applicable, to provide truthful testimony as required by law or any
     judicial or administrative process or the Executive from making normal
     commercial competitive type statements in a competitive business situation
     not based on his employment with the Company; and (ii) in no event shall
     any termination of the Executive's employment by the Company or the
     Executive for any reason constitute disparagement for purposes of this
     Section 9(e).

          (f) The Executive agrees that all strategies, methods, processes,
     techniques, marketing plans, merchandising schemes, themes, layouts,
     mechanicals, trade secrets, copyrights, trademarks, patents, ideas,
     specifications and other material or work product ("Intellectual Property")
     that the Executive creates, develops or assembles in connection with his
     employment hereunder shall become the permanent and exclusive property of
     the Company to be used in any manner it sees fit, in its sole discretion.
     The Executive shall not communicate to the Company any ideas, concepts, or
     other intellectual property of any kind (other than that required in his
     capacity as an officer of the Company) which (i) were earlier communicated
     to the Executive in confidence by any third party as proprietary
     information, or (ii) the Executive knows or has reason to know is the
     proprietary information of any third party. All Intellectual Property
     created or assembled in connection with the Executive's employment
     hereunder shall be the permanent and exclusive property of the Company. The
     Company and the Executive mutually agree that all Intellectual Property and
     work product created in connection with this Agreement, which is subject to
     copyright, shall be deemed to be "work made for hire," and that all rights
     to copyrights shall be vested in the Company. If for any reason the Company
     cannot be deemed to have commissioned "work made for hire," and its rights
     to copyright are thereby in doubt, then the Executive agrees not to claim
     to be the proprietor of the work prepared for the Company, and to
     irrevocably assign to the Company, at the Company's expense, all rights in
     the copyright of the work prepared for the Company.

          (g) The Company and the Executive expressly acknowledge and agree that
     the agreements and covenants contained in this Section 9 are reasonable. In
     the event, however, that any agreement or covenant contained in this
     Section 9 shall be determined by any court of competent jurisdiction to be
     unenforceable by reason of its

                                       16
<PAGE>

     extending for too great a period of time or over too great a geographical
     area or by reason of its being too extensive in any other respect, it will
     be interpreted to extend only over the maximum period of time for which it
     may be enforceable, and/or over the maximum geographical area as to which
     it may be enforceable and/or to the maximum extent in all other respects as
     to which it may be enforceable, all as determined by such court in such
     action.

          (h) As used in this Section 9, the term "Company" shall include the
     Company and any of its Affiliates or direct or indirect subsidiaries within
     the meaning of Code Section 424(f).

          (i) Any limitation on the Executive's activities or any forfeiture of
     benefits, equity or compensation based on violation of limitations on the
     Executive's activities shall not be based on any limitation that is any
     broader than those set forth in this Section 9.

     10. Specific Performance. It is recognized and acknowledged by the
Executive that a breach of the covenants contained in Section 9 will cause
irreparable damage to the Company and its goodwill, the exact amount of which
will be difficult or impossible to ascertain, and that the remedies at law for
any such breach will be inadequate. Accordingly, the parties agree that in the
event a party breaches any covenant contained in Section 9, in addition to any
other remedy which may be available at law or in equity (or under any other
agreement between the Company and the Executive), the other party will be
entitled to specific performance and injunctive relief.

     11. Purchases and Sales of the Company's Securities. The Executive agrees
to use his reasonable best efforts to comply in all respects with the Company's
applicable written policies regarding the purchase and sale of the Company's
securities by employees, as such written policies may be amended from time to
time and disclosed to the Executive. In particular, and without limitation, the
Executive agrees that he shall not purchase or sell Company securities (a) at
any time that he possesses material non-public information about the Company or
any of its businesses; and (b) while an employee during any "trading blackout
period" as may be determined by the Company and set forth in the Company's
applicable written policies from time to time.

     12. Indemnification. The Executive shall be entitled to indemnification set
forth in the Company's By-laws to the maximum extent allowed under the laws of
the State of Delaware, and he shall be entitled to the protection of any
insurance policies the Company may elect to maintain generally for the benefit
of its directors and officers against all costs, charges and expenses incurred
or sustained by him in connection with any action, suit or proceeding to which
he may be made a party by reason of his being or having been a director, officer
or employee of the Company or any of its subsidiaries or his serving or having
served any other enterprise or benefit plan as a director, officer, employee or
fiduciary at the request of the Company (other than any dispute, claim or
controversy arising under or relating to this Agreement). Notwithstanding
anything to the contrary herein, the Executive's rights under this Section 12
shall survive the termination of his employment for any reason and the
expiration of this Agreement for any reason.

                                       17
<PAGE>

     13. Cooperation Regarding Insurance. The Company and/or any of its
subsidiaries, divisions or Affiliates may, from time to time, apply for and
obtain, for its or their benefit and at its or their sole expense, key man life,
health, accident, disability, or other insurance upon the Executive, in any
amounts that it or they may deem necessary or desirable to protect its or their
respective interests, and the Executive agrees to reasonably cooperate with and
assist the Company or any such subsidiary, division or Affiliate in obtaining
any and all such insurance by submitting to all reasonable medical examinations,
if any, and by filling out, executing and delivering any and all insurance
applications and other instruments as may be reasonably necessary to obtain such
insurance.

     14. No Conflicting Agreements. The Executive hereby represents and warrants
that he is not a party to or bound by any agreement, arrangement or
understanding, written or otherwise, which prohibits or in any manner restricts
his ability to enter into and fulfill his obligations under this Agreement
(other than confidentiality obligations with any of the Executive's prior
employers). The parties acknowledge and agree that the Executive shall not use
of disclose, or be permitted to use or disclose, any confidential or proprietary
information belonging to any prior employer in connection with the performance
of his duties under this Agreement.

     15. Delegation and Assignment. The Executive shall not delegate his
employment obligations under this Agreement to any other person. The Company may
not assign any of its obligations hereunder other than to any entity that
acquires (by purchase, merger or otherwise) all or substantially all of the
Voting Stock or assets of the Company, provided such acquirer promptly assumes
all of the obligations hereunder of the Company in a writing delivered to the
Executive. In the event of the Executive's death while he is receiving severance
hereunder the remainder shall be paid to his estate.

     16. Notices. Any written notice required by this Agreement will be deemed
provided and delivered to the intended recipient when (a) delivered in person by
hand; or (b) three days after being sent via U.S. certified mail, return receipt
requested; or (c) the day after being sent via by overnight courier, in each
case when such notice is properly addressed to the following address and with
all postage and similar fees having been paid in advance:

     If to the Company:     Symbol Technologies, Inc.
                            One Symbol Plaza
                            Holtsville, New York 11742-1300
                            Attn: General Counsel

     with a copy to:        Latham & Watkins LLP
                            885 Third Avenue, Suite 1000
                            New York, NY 10022
                            Attn: Bradd L. Williamson

     If to the Executive:   to him at the most recent address in the Company's
                            records.

                                       18
<PAGE>

Either party may change the address to which notices, requests, demands and
other communications to such party shall be delivered personally or mailed by
giving written notice to the other party in the manner described above.

     17. Legal Fees. The Company shall pay the Executive's reasonable attorneys'
fees and disbursements incurred by him in connection with the negotiation of
this Agreement; subject to a cap of $25,000.

     18. Binding Effect. This Agreement shall be for the benefit of and binding
upon the parties hereto and their respective heirs, personal representatives,
legal representatives, successors and, where applicable, assigns.

     19. Entire Agreement. This Agreement constitutes the entire agreement
between the parties with respect to the subject matter described in this
Agreement and supersedes all prior agreements, understandings and arrangements,
both oral and written, between the parties with respect to such subject matter,
including, without limitation, the Employment Agreement between the Company and
the Executive dated as of July 15, 2002 (the "Prior Agreement"); provided,
however, that any written agreements between the Executive and the Company
concerning Option or any other equity compensation awards shall remain in full
force and effect in accordance with their terms. This Agreement may not be
modified, amended, altered or rescinded in any manner, except by written
instrument signed by both of the parties hereto; provided, however, that the
waiver by either party of a breach or compliance with any provision of this
Agreement shall not operate nor be construed as a waiver of any subsequent
breach or compliance.

     20. Agreement Not to Sell Certain Shares. The Executive hereby reaffirms
his agreement, as set forth in Section 4(f) of the Prior Agreement, not to sell
the 400,000 shares of Common Stock he was granted pursuant to Section 4(e) of
the Prior Agreement prior to the earlier of (a) August 1, 2004 or (b) the
termination of his employment for any reason.

     21. Severability. In case any one or more of the provisions of this
Agreement shall be held by any court of competent jurisdiction or any arbitrator
selected in accordance with the terms hereof to be illegal, invalid or
unenforceable in any respect, such provision shall have no force and effect, but
such holding shall not affect the legality, validity or enforceability of any
other provision of this Agreement.

     22. Dispute Resolution and Arbitration. In the event that any dispute
arises between the Company and the Executive regarding or relating to this
Agreement and/or any aspect of the Executive's employment relationship with the
Company, AND IN LIEU OF LITIGATION AND A TRIAL BY JURY, the parties consent to
resolve such dispute through mandatory arbitration in Suffolk County, New York
under the then prevailing rules of the Judicial Arbitration and Mediation
Services ("JAMS"), before a single arbitrator mutually agreed to by the parties,
or, if an arbitrator has not been agreed upon by the 60th day of the demand for
arbitration by either party, appointed by JAMS. The parties hereby consent to
the entry of judgment upon award rendered by the arbitrator in any court of
competent jurisdiction. Notwithstanding the foregoing, however, should adequate
grounds exist for seeking immediate injunctive or immediate equitable relief,
any party may seek and obtain such relief. The parties

                                       19
<PAGE>

hereby consent to the exclusive jurisdiction in the state and Federal courts of
or in the State of New York for purposes of seeking such injunctive or equitable
relief as set forth above. The parties acknowledge and agree that in connection
with any such arbitration and regardless of outcome (a) each party shall pay all
its own costs and expenses, including without limitation its own legal fees and
expenses, and (b) joint expenses shall be borne equally among the parties.
Notwithstanding the foregoing, the arbitrator may cause the losing party to pay
to the winning party (each as determined by the arbitrator consistent with its
decision on the merits of the arbitration) an amount equal to any reasonable
out-of-pocket costs and expenses incurred by the winning party with respect to
such arbitration (as may be equitably determined by the arbitrator).

     23. Choice of Law. The Executive and the Company intend and hereby
acknowledge that jurisdiction over disputes with regard to this Agreement, and
over all aspects of the relationship between the parties hereto, shall be
governed by the laws of the State of New York without giving effect to its rules
governing conflicts of laws.

     24. Section Headings. The section headings contained in this Agreement are
for reference purposes only and shall not affect in any manner the meaning or
interpretation of this Agreement.

     25. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original, but all of which taken
together shall constitute one and the same instrument.

     26. Force Majeure. Neither Company nor the Executive shall be liable for
any delay or failure in performance of any part of this Agreement to the extent
that such delay or failure is caused by an event beyond its reasonable control
including, but not be limited to, fire, flood, explosion, war, strike, embargo,
government requirement, acts of civil or military authority, and acts of God not
resulting from the negligence of the claiming party.

     27. Withholding. The Company shall be entitled to withhold from any amounts
payable under this Agreement any federal, state, local or foreign withholding or
other taxes or charges which the Company is required to withhold. The Company
shall be entitled to rely on an opinion of counsel if any questions as to the
amount or requirement of withholding shall arise.

                            [signature page follows]

                                       20
<PAGE>

     IN WITNESS WHEREOF, the parties have executed this Agreement on the date
and year first above written.

                                       SYMBOL TECHNOLOGIES, INC.

                                       By:  /s/  Peter M. Lieb
                                            ------------------------------------
                                       Its: Senior Vice President,
                                            General Counsel & Secretary

                                       EXECUTIVE

                                       /s/ William R. Nuti
                                       -----------------------------------------
                                       William R. Nuti

                                       21

<PAGE>

                                                                       EXHIBIT A

[Date]

Re:  Separation and Release Agreement
     --------------------------------

Dear      :

This letter sets forth certain terms and conditions relative to your separation
from your employment with Symbol Technologies, Inc., including its subsidiaries
and affiliated corporations, and their respective current and former directors,
officers, employees, agents and assigns ("Symbol" or the "Company").

Your resignation from Symbol's employ will be effective    . After you execute
and return this Agreement to the Company, which you acknowledge may not be
executed prior to your last day of actual work, the Company will provide you
with severance payments and benefits to the extent provided by that certain
Employment Agreement between you and the Company dated as of March 31, 2004.

In exchange for the Company providing you with the aforementioned severance
payments and benefits, you hereby waive all claims against the Company and
unconditionally and irrevocably release and discharge the Company from liability
for any claims or damages that you have or may have against it, its current and
former directors, officers, employees, agents and assigns up to the moment this
Agreement becomes fully executed, regardless of whether those claims are known
or unknown including, but not limited to, any claims for wages, severance
(except as specifically provided for herein), bonuses or benefits (except as
specifically provided for herein), or any other claims whatsoever arising during
or, in whole or in part, out of your employment relationship with the Company,
or violations of any federal, state or local fair employment statute, executive
order, ordinance, law or regulation, including Title VII of the Civil Rights
Act, the Rehabilitation Act of 1973, the Americans With Disabilities Act, the
Age Discrimination in Employment Act, as amended by the Older Workers' Benefit
Protection Act, the New York State Human Rights Law, or any other potentially
applicable employment or labor law, or any other rule of law or common law
including, but not limited to those concerning possible torts, express or
implied contract, the implied covenant of good faith and fair dealing, public
policy, or other obligations. Other than with respect to any rights to which you
may be entitled under the federal Age Discrimination in Employment Act, you also
agree not to initiate any administrative or legal action against the Company to
assert such claims. Moreover, to the extent any such action is brought by you or
on your behalf by any third party, you agree to waive all claims to monetary
relief or damages of any kind, including attorneys' fees and costs. You
understand that the fact of this agreement and/or the agreement to pay or the
payment of the consideration described herein does not constitute an admission
by the Company that it has violated any such law or legal obligation.

You acknowledge that you may take up to twenty-one (21) days to consider the
terms of this Agreement. You also acknowledge that you were advised by Symbol to
discuss the terms of this Agreement with your attorneys prior to signing this
Agreement. You further acknowledge that you are entering into this Agreement,
freely, knowingly, and voluntarily, with a full understanding of its terms and
that you will

<PAGE>

[Name]
[date]
Page 2 of 2

have 7 days to revoke this Agreement after executing the same by
notifying the undersigned in writing during this seven-day period. Except as set
forth herein, this constitutes the entire agreement between us regarding the
subject matter hereof. This Agreement may not be changed or altered, except by a
writing signed by you and the Company. This Agreement is entered into in the
State of New York and the laws of the State of New York will apply to any
dispute concerning it, without regard to its conflicts of law provisions. If any
clause of this Agreement should ever be determined to be unenforceable, it is
agreed that this will not affect the enforceability of any other clause or the
remainder of this Agreement.

Sincerely,

Symbol Technologies, Inc.

AGREED AND ACCEPTED:

By:                                         Date:
     -----------------------------                -----------------
     [Name]

On this _____ day of _________, 2004 before me personally came ________________,
to me known to be the individual described in and who executed the foregoing
Separation Agreement, and duly acknowledged to me that he executed the same.

------------------------------
Notary Public

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00064-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00064-of-00352.parquet"}]]